Tag Archives: Cannabis pets

CannPal Commences Phase 1B Study for Lead Drug Candidate CPAT-01D

Animal health company CannPal Animal Therapeutics Limited (ASX:CP1) (“CannPal” or “the Company”) is pleased to announce that it has commenced Phase 1B of the Pharmacokinetic and Safety study for CPAT-01D, a cannabis-derived veterinary medicine being developed as a pain control in dogs. Key Highlights Commenced Phase 1B of the Pharmacokinetic and Safety study for CPAT-01D, a cannabis-derived … Continue reading

September 5, 2018 Latest News, News

CannPal Enters MOU with The University of Melbourne to Research Epilepsy Treatment for Dogs

8th August 2018: Animal health company CannPal Animal Therapeutics Limited (ASX:CP1) (“CannPal” or “the Company”) is pleased to announce it has entered into a Memorandum of Understanding (MOU) with The University of Melbourne (‘the University’) to broaden the Company’s research pipeline. Key Highlights CannPal has entered into a Memorandum of Understanding with The University of Melbourne for veterinary … Continue reading

August 8, 2018 Latest News, News

Cannabidiol Officially Classed as Medicine in the UK

CBD (Cannabidiol) the phytocannabinoid derived for cannabis, is now officially classified as an ingredient in medical products. The MHRA requires manufacturers to meet the safety standards, quality and effectiveness standards that you would expect from any other medicine. This is a very positive step forward for medicinal cannabis compounds and this decision now closely mimics … Continue reading

January 19, 2017 News